and wild type. In addition, the initial dose of CPT-11 / 5-FU bolus, initial relative dose intensity (RDI) ( ), and blood toxicity in the first course were investigated. Mean age was 70.4 8.6
years, UGT1A1 genotype was 28 he in 5 cases, 6 he in 6 cases, and wild type in 14 cases. There were no cases of compound he or homo type. There was no significant difference between the initial dose and the initial RDI. Reduction in leukocyte count was seen in 2 cases with Grade (G) 3 6 he and in 2 cases with G4 28 he. Platelet count was reduced in 2 cases with G4 28 he, 2 cases with G4 2 he, 2 cases with G4 28 he, and in 2 cases with 6 he. In this study, there was no significant difference in the initial dose and initial RDI for 6 he, 28 he, and wild type.
However, 28 he and 6 he showed hematologic toxicity of G3 or more. Also, the frequency of the he genotype tended to be higher than that of wild type. Thus, it is necessary to clarify the significance of weight loss in the he type in future.
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